Rare Immune Cell May Predict Immunotherapy Response in Melanoma
Source: CureToday, January 2024
Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.
A rare type of immune cell has been found to potentially predict how likely it is that certain patients with skin cancer will be responsive to treatment via immunotherapy, according to recently published research.
A team of British researchers from King’s College London, Guy’s and St Thomas’ Hospital Trust and the Francis Crick Institute, who reported their findings in a study published in the journal Nature Cancer, found that Vd1-gd T cells had the ability to recognize and kill cancer cells without identifying mutations, and can be found inside tumors where the immune checkpoint protein programmed cell death protein 1 (PD-1) is also present, as explained in a news release issued by King’s College London.